TANG CAPITAL PARTNERS LP 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-05 4:34 pm Sale | 2023-05-03 | 13D | Jounce Therapeutics, Inc. JNCE | TANG CAPITAL PARTNERS LP | 10,000 100.000% | -5,290,087 (-99.81%) | Filing |
| 2023-04-07 4:00 pm Unchanged | 2023-04-05 | 13D | Jounce Therapeutics, Inc. JNCE | TANG CAPITAL PARTNERS LP | 5,300,087 10.200% | 0 (Unchanged) | Filing |
| 2023-03-28 4:00 pm Unchanged | 2023-03-26 | 13D | Jounce Therapeutics, Inc. JNCE | TANG CAPITAL PARTNERS LP | 5,300,087 10.200% | 0 (Unchanged) | Filing |
| 2023-03-17 4:00 pm Unchanged | 2023-03-17 | 13D | Jounce Therapeutics, Inc. JNCE | TANG CAPITAL PARTNERS LP | 5,300,087 10.200% | 0 (Unchanged) | Filing |
| 2023-03-14 5:00 pm Purchase | 2023-03-14 | 13D | Jounce Therapeutics, Inc. JNCE | TANG CAPITAL PARTNERS LP | 5,300,087 10.200% | 300,087 (+6.00%) | Filing |
| 2023-03-06 4:00 pm Purchase | 2023-02-23 | 13G | Jounce Therapeutics, Inc. JNCE | TANG CAPITAL PARTNERS LP | 5,000,000 9.700% | 5,000,000 (New Position) | Filing |